Are Mushrooms Good for Diabetes and Blood Sugar?

Mushrooms show genuine promise for blood sugar management, with lab studies, animal trials, and a handful of human experiments pointing to measurable glucose-lowering effects. The catch is that most of the strongest evidence comes from rodent models and test-tube experiments, while human clinical data remains thin and mixed. Several species, including white button, oyster, maitake, and shiitake mushrooms, contain compounds that interfere with how your body digests and absorbs sugar. Whether eating mushrooms at dinner translates into meaningful improvements for someone managing diabetes is a more complicated question than supplement marketing would have you believe.

How Mushrooms Interfere With Sugar Absorption

The most well-documented way mushrooms affect blood sugar involves slowing down how quickly your body breaks starch into glucose. When you eat carbohydrate-rich food, enzymes in your saliva and intestines chop starch molecules into simple sugars. Mushrooms contain compounds that inhibit two key enzymes in this process. Several mushroom species have shown strong inhibitory activity against both of these starch-digesting enzymes in lab tests, with some extracts performing comparably to acarbose, a prescription drug designed to do the same thing.¹ When these enzymes are partially blocked, glucose trickles into your bloodstream more gradually rather than flooding in all at once, which flattens the spike you get after a meal.

Beyond enzyme inhibition, mushroom compounds also appear to work inside cells. Terpenoids found in various species activate a receptor that helps cells respond to insulin more effectively, reducing the hyperglycemia seen in animal models of diabetes.² Meanwhile, beta-glucan-rich extracts from oyster mushrooms have been shown to activate a cellular energy sensor called AMPK, which in turn promotes the movement of glucose transporters to the cell surface so that cells pull more sugar out of the blood.³ Shiitake mushroom extracts produced a similar effect in cell models of type 2 diabetes, with significant increases in both glucose uptake and the expression of GLUT4, the transporter that lets muscle and fat cells absorb glucose.⁴

A third mechanism involves the fiber itself physically slowing things down. Beta-glucans from lion’s mane mushroom showed strong glucose diffusion-retarding activity in lab simulations and reduced starch breakdown during simulated digestion.⁵ Think of it as a gel-like barrier that physically delays glucose from reaching your intestinal wall. This is not unique to mushrooms; soluble fibers from oats and barley do something similar. But mushroom beta-glucans appear to combine this physical effect with the enzyme-blocking properties, which may give them an edge per gram of fiber.

What Happens When People Actually Eat Mushrooms

The challenge with mushroom research is the enormous gap between lab findings and real-world outcomes. Most of the dramatic blood sugar reductions come from animal studies using concentrated extracts at doses that do not easily map onto what you would eat at dinner. Human trials exist, but they are few and often small.

An eight-week randomized controlled trial gave people with type 2 diabetes dried white button mushroom powder daily. Fructosamine, a marker of blood sugar control over the preceding two to three weeks, dropped meaningfully in the mushroom group compared to controls. Fasting blood sugar fell within the mushroom group itself, and insulin resistance improved from about 4.9 to 3.8 on the standard index, though the difference between the mushroom and control groups for fasting glucose did not reach statistical significance.⁶ That is a common pattern in this literature: improvements show up within the mushroom group, but comparing directly to a placebo group often yields modest or non-significant differences.

A small trial in people with diabetes found that oyster mushroom consumption significantly lowered both fasting and post-meal blood glucose. When the mushroom was withdrawn, glucose levels rose again, and when it was reintroduced, they dropped back down, creating a convincing on-off pattern.⁷ A separate study in people with metabolic obesity found that a meal containing king oyster mushroom produced a lower glucose response compared to a control meal, an effect the researchers attributed to the mushroom’s polysaccharides slowing carbohydrate digestion and delaying stomach emptying.⁸

A separate study in adults with metabolic syndrome who ate white button mushrooms daily for sixteen weeks found doubled levels of ergothioneine and improved antioxidant markers, but no change in insulin resistance or glucose metabolism.⁹ So even within the same species, the specific blood sugar outcome depends on the population studied, the form of the mushroom, and how long the study runs.

The Reishi Disappointment

Reishi mushroom deserves its own discussion because it is one of the most heavily marketed species for metabolic health, and the clinical evidence flatly contradicts the marketing. A double-blind, randomized, placebo-controlled trial testing reishi extract in people with diabetes or metabolic syndrome found no effect on HbA1c, fasting glucose, or any other cardiovascular risk factor over sixteen weeks.¹⁰ A systematic review and meta-analysis of reishi studies in humans came to the same conclusion: no significant differences in fasting glucose, cholesterol fractions, or other metabolic markers in people with metabolic syndrome.¹¹

This matters because reishi extracts and supplements are widely sold at premium prices with claims about blood sugar support. The best human evidence currently available says those claims are not supported. Reishi may have other properties worth studying, but if your primary goal is blood sugar management, the rigorous trials say to look elsewhere.

Which Species Show the Most Promise

Not all mushrooms are equal when it comes to blood sugar effects. The research landscape is broad, with hypoglycemic effects observed across at least ten species in lab and animal work.¹² But a few stand out for having evidence across multiple study types.

Oyster mushrooms have perhaps the broadest evidence base. Beyond the human trial already mentioned, a rat study found that oyster mushroom treatment reduced fasting glucose by about 29% over eight weeks, with AMPK activation and increased GLUT4 expression in muscle tissue confirming the mechanism at the cellular level.¹³ The combination of human trial data, animal model confirmation, and identified cellular mechanisms makes oyster mushrooms one of the better-supported options.

Maitake mushroom extracts have shown blood sugar-lowering effects in insulin-resistant mice, with glucose concentrations dropping roughly 25% and both glucose and insulin levels falling over a week-long feeding period, suggesting the mushroom improves how well cells respond to insulin rather than just forcing more insulin production.¹⁴ A separate rat study found that maitake polysaccharides lowered fasting glucose and insulin resistance scores to a degree comparable to metformin, and linked the effect to changes in gut bacteria composition.¹⁵ Maitake’s limitation is that its human clinical data is essentially nonexistent, so the promising animal results have not been confirmed in people.

Shiitake mushrooms are well studied for their beta-glucan content. In one animal experiment, beta-glucan extracted from shiitake reduced blood glucose by about 56% in diabetic mice, comparable to the performance of a pharmaceutical-grade beta-glucan and not significantly different from the diabetes drug glibenclamide. The researchers attributed this to delayed gastric emptying, meaning the sugar from food enters the intestines more slowly.¹⁶ A comparison study in diabetic rats found that shiitake-supplemented diets outperformed oyster-mushroom-supplemented diets in lowering fasting blood glucose and improving antioxidant markers.¹⁷

The Weight Loss Angle

Even if mushrooms had zero direct pharmacological effects on blood sugar, they would still be useful for people with diabetes for a simpler reason: they are extremely low in calories and high in fiber, making them an effective replacement for calorie-dense foods. A year-long randomized clinical trial compared obese adults who substituted mushrooms for red meat against those who followed a standard diet. Over twelve months, the mushroom group lost about seven more pounds, reduced their waist circumference, lowered body fat percentage, and saw improvements in blood pressure and lipid profiles.¹⁸ They also maintained that weight loss through the end of the trial. Since excess weight is one of the strongest drivers of insulin resistance, this dietary swap has indirect but real implications for blood sugar control, even without invoking beta-glucans or enzyme inhibition.

The calorie math is straightforward. A cup of sliced white button mushrooms has roughly 15 to 20 calories. The same volume of ground beef has about ten times that. Mushrooms also provide more satiety than their calorie count would suggest, partly because of their fiber content and partly because of their umami flavor and meaty texture, which make them satisfying as a main-dish component rather than just a garnish.

Does Cooking Method Matter

How you prepare mushrooms affects their blood sugar-related bioactivity, and the findings are somewhat counterintuitive. In a study examining six cooking methods applied to a wild mushroom species, water-based methods like boiling, steaming, and microwaving produced the highest hypoglycemic activity after simulated digestion, despite having lower antioxidant activity than oil-based methods like frying and roasting.¹⁹ A separate study confirmed this pattern, finding that microwaving stood out for producing the strongest blood sugar-lowering activity in lab digestion models.²⁰

The likely explanation is that water-based cooking preserves the polysaccharides and beta-glucans responsible for enzyme inhibition, while high-heat oil methods may degrade some of these compounds or alter their structure. This does not mean you should never sauté mushrooms in oil, but if maximizing their potential blood sugar benefit is a priority, steaming or adding them to soups and stews is probably more effective than deep frying.

Mushrooms and Gut Bacteria

An emerging line of research connects mushrooms to blood sugar through the gut microbiome. Mushroom polysaccharides act as prebiotics, selectively feeding beneficial gut bacteria and increasing the production of short-chain fatty acids.²¹ Short-chain fatty acids have been independently linked to improved insulin sensitivity and reduced inflammation in the gut lining. The maitake study mentioned earlier found that its blood sugar benefits were associated with favorable shifts in gut bacteria composition, adding a plausible pathway between eating mushrooms and metabolic improvement that goes beyond direct enzyme inhibition.¹⁵

Mushrooms are also among the most concentrated food sources of ergothioneine, a modified amino acid that accumulates in tissues exposed to oxidative stress. Ergothioneine has been proposed as protective against cardiovascular and metabolic diseases driven by chronic inflammation.²² This does not mean eating mushrooms will treat diabetes through antioxidant activity, but it adds another way that regular consumption could contribute to metabolic health over time, particularly in reducing the oxidative damage that worsens diabetic complications.

Drug Interactions and Safety Concerns

If you take medication for diabetes, the blood sugar-lowering properties of mushrooms are not purely a good thing. An animal study found that an oyster mushroom extract produced a synergistic glucose-lowering effect when combined with glyburide, a common sulfonylurea diabetes drug. The combination drove blood sugar down more than either treatment alone.²³ In clinical practice, “synergistic” is not always a compliment. An unexpectedly large drop in blood sugar is hypoglycemia, and it can be dangerous.

This interaction was demonstrated with a concentrated mushroom extract, not a plate of sautéed mushrooms at dinner. Eating normal portions of culinary mushrooms alongside diabetes medication is unlikely to cause problems for most people. But if you are taking mushroom supplements, especially high-dose polysaccharide extracts, and you are also on sulfonylureas, insulin, or other glucose-lowering drugs, the combination could amplify the effect beyond what either alone would produce. This is worth mentioning to your doctor, particularly because mushroom supplements are not regulated with the same precision as pharmaceuticals, and doses vary wildly between products.

Mushrooms themselves are generally well-tolerated. The clinical trials cited in this article reported no significant adverse events. The main practical concern is quality control in the supplement space: products labeled as containing specific mushroom species and standardized polysaccharide content may not actually deliver what the label claims, since supplement regulation does not require the same manufacturing oversight as drugs. Whole mushrooms from a grocery store avoid this problem entirely.

Supplements Versus Whole Mushrooms

The distinction between eating mushrooms as food and taking mushroom extracts as supplements matters more than most people realize. Nearly all the dramatic percentage drops in blood glucose come from studies using concentrated extracts, often administered at doses equivalent to eating implausible quantities of whole mushrooms. A vanadium-enriched shaggy mane mushroom extract lowered blood glucose and glycohemoglobin in diabetic mice while improving glycogen synthesis and sugar tolerance, but the mushrooms had been specially fermented with trace elements to concentrate the active compounds.²⁴ You cannot replicate this by adding shaggy mane mushrooms to your stir-fry.

Whole culinary mushrooms do deliver beta-glucans, ergothioneine, and the enzyme-inhibiting compounds discussed throughout this article, just at lower concentrations. Their advantage is that they also deliver fiber, low calories, potassium, B vitamins, and the opportunity to displace higher-calorie foods from your plate. The year-long meat substitution trial showed that this displacement effect produces real metabolic benefits in its own right.¹⁸ A reasonable takeaway is that whole mushrooms eaten regularly as part of meals offer a modest, multifaceted benefit for blood sugar and metabolic health, while supplements offer a chance at stronger pharmacological effects with much less certainty about safety, dose accuracy, and real-world outcomes.

Nobody has run the large, multi-year randomized trials needed to say with confidence that any mushroom species reliably improves HbA1c in humans with type 2 diabetes. The science is promising at the mechanistic level and encouraging in small trials, but the reishi example shows how easily promising lab data can fail to translate into human benefit. Mushrooms are a genuinely nutritious food that belongs in a diabetes-friendly diet for straightforward reasons. Whether their bioactive compounds produce clinically meaningful glucose-lowering effects in everyday eating remains an open question that the research is still working to answer.